Across TCGA pan-cancer cohorts, CAMTA1-AS1 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated CAMTA1-AS1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher CAMTA1-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CAMTA1-AS1 expression acts as an unfavorable survival marker, although some lineages such as BRCA and ESCA show a favorable association.

ACC, BRCA, and LGG are the cancer types where CAMTA1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.231	0.671	<.001	111	view →
BRCA	OS	Median	All	0.951	0.897	<.001	94	view →
LGG	DFS	Median	All	0.607	0.824	<.001	54	view →
COAD	DFS	Tertile	All	0.237	0.544	.002	39	view →
STAD	DFS	Median	All	0.269	0.641	.002	29	view →
UVM	OS	Tertile	All	0.317	0.751	<.001	27	view →
CHOL	OS	Median	IV	0.208	0.948	.010	24	view →
MESO	OS	Median	All	0.302	0.667	.005	24	view →
ESCA	OS	Tertile	II,III,IV	0.717	0.408	.004	20	view →
LAML	DFS	Tertile	All	0.656	0.318	.017	18	view →
LUAD	DFS	Tertile	All	0.846	0.765	.012	14	view →
UCEC	OS	Quartile	III,IV	0.828	0.530	.013	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

Exploration

Same gene, other analysis: CAMTA1-AS1 tumor-vs-normal RNA expression · all CAMTA1-AS1 data types